ArticleAmerican journal of perinatology2026

Design of a Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of Nipocalimab in Pregnancies at Risk for Fetal and Neonatal Alloimmune Thrombocytopenia.

Heidi Tiller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.